Table 1

Sex and prescribed medications during the IBP in all subjects and according to age group

Gender/drug categoryAll subjectsAge groupsP value
77–81 years82–86 years87–91 years≥92 years
Number of subjects42 02418 23212 34669424504
n%n%n%n%n%
Female23 76656.6940551.6678054.9425261.3332973.9<0.0001
Cardiometabolic drugs
 Antihypertensives17 23741442624.3661953.6385855.6233451.8<0.0001
 Statins716517219412303624.6140720.352811.7<0.0001
 Antiplatelets700716.716629.1264721.4166324103523<0.0001
 Oral antidiabetics34288.210725.9146111.86399.22565.7<0.0001
 Antianginals20214.83822.16835.55147.44429.8<0.0001
 Anticoagulants15073.63822.16004.93555.11703.8<0.0001
 Insulin6771.62031.12952.41341.9451<0.0001
Drugs for CNS
 Benzodiazepines38649.29885.4153012.488412.746210.3<0.0001
 Antidepressants10642.52501.44293.52643.81212.7<0.0001
 Poststroke medications9072.22211.23272.62213.21383.1<0.0001
Others
 Antineoplastics801119.1219712.1325726.4165523.890220<0.0001
 NSAIDs, regular use32057.66793.712381081311.747510.5<0.0001
 Non-steroidal bronchodilators208555102.87726.34786.93257.2<0.0001
 Steroids, oral or inhaled168544612.56735.53855.51663.7<0.0001
  • CNS, central nervous system; IBP, initial background period (from 1 April to 30 June 2012); NSAID, non-steroidal anti-inflammatory drug.